396 related articles for article (PubMed ID: 11784136)
1. Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties.
Masereel B; Rolin S; Abbate F; Scozzafava A; Supuran CT
J Med Chem; 2002 Jan; 45(2):312-20. PubMed ID: 11784136
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase inhibitors: aromatic and heterocyclic sulfonamides incorporating adamantyl moieties with strong anticonvulsant activity.
Ilies MA; Masereel B; Rolin S; Scozzafava A; Câmpeanu G; Cîmpeanu V; Supuran CT
Bioorg Med Chem; 2004 May; 12(10):2717-26. PubMed ID: 15110853
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibitors. Design of anticonvulsant sulfonamides incorporating indane moieties.
Chazalette C; Masereel B; Rolin S; Thiry A; Scozzafava A; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2004 Dec; 14(23):5781-6. PubMed ID: 15501040
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibitors. Inhibition of isoforms I, II, IV, VA, VII, IX, and XIV with sulfonamides incorporating fructopyranose-thioureido tails.
Winum JY; Thiry A; Cheikh KE; Dogné JM; Montero JL; Vullo D; Scozzafava A; Masereel B; Supuran CT
Bioorg Med Chem Lett; 2007 May; 17(10):2685-91. PubMed ID: 17376683
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV.
Casini A; Antel J; Abbate F; Scozzafava A; David S; Waldeck H; Schäfer S; Supuran CT
Bioorg Med Chem Lett; 2003 Mar; 13(5):841-5. PubMed ID: 12617904
[TBL] [Abstract][Full Text] [Related]
6. Pyridazinone substituted benzenesulfonamides as potent carbonic anhydrase inhibitors.
Yaseen R; Ekinci D; Senturk M; Hameed AD; Ovais S; Rathore P; Samim M; Javed K; Supuran CT
Bioorg Med Chem Lett; 2016 Feb; 26(4):1337-41. PubMed ID: 26804228
[TBL] [Abstract][Full Text] [Related]
7. Novel sulfonamides incorporating 1,3,5-triazine and amino acid structural motifs as inhibitors of the physiological carbonic anhydrase isozymes I, II and IV and tumor-associated isozyme IX.
Mikuš P; Krajčiová D; Mikulová M; Horváth B; Pecher D; Garaj V; Bua S; Angeli A; Supuran CT
Bioorg Chem; 2018 Dec; 81():241-252. PubMed ID: 30153589
[TBL] [Abstract][Full Text] [Related]
8. Discovery of potent anti-convulsant carbonic anhydrase inhibitors: Design, synthesis, in vitro and in vivo appraisal.
Mishra CB; Kumari S; Angeli A; Bua S; Buonanno M; Monti SM; Tiwari M; Supuran CT
Eur J Med Chem; 2018 Aug; 156():430-443. PubMed ID: 30015076
[TBL] [Abstract][Full Text] [Related]
9. Continued exploration and tail approach synthesis of benzenesulfonamides containing triazole and dual triazole moieties as carbonic anhydrase I, II, IV and IX inhibitors.
Vats L; Kumar R; Bua S; Nocentini A; Gratteri P; Supuran CT; Sharma PK
Eur J Med Chem; 2019 Dec; 183():111698. PubMed ID: 31539777
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors.
Kumar R; Vats L; Bua S; Supuran CT; Sharma PK
Eur J Med Chem; 2018 Jul; 155():545-551. PubMed ID: 29909339
[TBL] [Abstract][Full Text] [Related]
11. A class of sulfonamides as carbonic anhydrase I and II inhibitors.
Gokcen T; Gulcin I; Ozturk T; Goren AC
J Enzyme Inhib Med Chem; 2016; 31(sup2):180-188. PubMed ID: 27353698
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of benzenesulphonamide-bearing 1,4,5-trisubstituted-1,2,3-triazoles possessing human carbonic anhydrase I, II, IV, and IX inhibitory activity.
Kumar R; Sharma V; Bua S; Supuran CT; Sharma PK
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1187-1194. PubMed ID: 28891338
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and carbonic anhydrase inhibitory activities of new thienyl-substituted pyrazoline benzenesulfonamides.
Mete E; Comez B; Inci Gul H; Gulcin I; Supuran CT
J Enzyme Inhib Med Chem; 2016; 31(sup2):1-5. PubMed ID: 27435177
[TBL] [Abstract][Full Text] [Related]
14. Anticonvulsant sulfonamides/sulfamates/sulfamides with carbonic anhydrase inhibitory activity: drug design and mechanism of action.
Thiry A; Dogné JM; Supuran CT; Masereel B
Curr Pharm Des; 2008; 14(7):661-71. PubMed ID: 18336312
[TBL] [Abstract][Full Text] [Related]
15. Comparison of sulfamate and sulfamide groups for the inhibition of carbonic anhydrase-II by using topiramate as a structural platform.
Maryanoff BE; McComsey DF; Costanzo MJ; Hochman C; Smith-Swintosky V; Shank RP
J Med Chem; 2005 Mar; 48(6):1941-7. PubMed ID: 15771438
[TBL] [Abstract][Full Text] [Related]
16. Salts of 5-amino-2-sulfonamide-1,3,4-thiadiazole, a structural and analog of acetazolamide, show interesting carbonic anhydrase inhibitory properties, diuretic, and anticonvulsant action.
Diaz JR; Camí GE; Liu-González M; Vega DR; Vullo D; Juárez A; Pedregosa JC; Supuran CT
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1102-10. PubMed ID: 26497704
[TBL] [Abstract][Full Text] [Related]
17. Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies.
Eldehna WM; Al-Ansary GH; Bua S; Nocentini A; Gratteri P; Altoukhy A; Ghabbour H; Ahmed HY; Supuran CT
Eur J Med Chem; 2017 Feb; 127():521-530. PubMed ID: 28109946
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.
Vullo D; Voipio J; Innocenti A; Rivera C; Ranki H; Scozzafava A; Kaila K; Supuran CT
Bioorg Med Chem Lett; 2005 Feb; 15(4):971-6. PubMed ID: 15686895
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase inhibitors: synthesis and topical intraocular pressure lowering effects of fluorine-containing inhibitors devoid of enhanced reactivity.
de Leval X; Ilies M; Casini A; Dogné JM; Scozzafava A; Masini E; Mincione F; Starnotti M; Supuran CT
J Med Chem; 2004 May; 47(11):2796-804. PubMed ID: 15139757
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.
Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
Bioorg Med Chem; 2009 Jul; 17(14):4894-9. PubMed ID: 19539481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
